BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25845550)

  • 21. Minimally invasive awake craniotomy using Steiner-Lindquist stereotactic laser guidance.
    Bekar A; Bilgin H; Korfali G; Korfali E; Kocaeli H; Taskapiğlu O
    Minim Invasive Neurosurg; 2009 Aug; 52(4):176-9. PubMed ID: 19838971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcortical injury is an independent predictor of worsening neurological deficits following awake craniotomy procedures.
    Trinh VT; Fahim DK; Shah K; Tummala S; McCutcheon IE; Sawaya R; Suki D; Prabhu SS
    Neurosurgery; 2013 Feb; 72(2):160-9. PubMed ID: 23147778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of cavernous malformations in supratentorial eloquent areas: experience after 10 years of patient-tailored surgical protocol.
    Sanmillan JL; Lopez-Ojeda P; Fernández-Conejero I; Fernández-Coello A; Plans G; Ali-Ciurana Y; Gabarrós A
    Acta Neurochir (Wien); 2018 Oct; 160(10):1963-1974. PubMed ID: 30091050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multimodal Surgical Management of Cerebral Lesions in Motor-Eloquent Areas Combining Intraoperative 3D Ultrasound with Neurophysiological Mapping.
    Policicchio D; Ticca S; Dipellegrini G; Doda A; Muggianu G; Boccaletti R
    J Neurol Surg A Cent Eur Neurosurg; 2021 Jul; 82(4):344-356. PubMed ID: 33352612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraoperative magnetic resonance imaging-guided tractography with integrated monopolar subcortical functional mapping for resection of brain tumors. Clinical article.
    Prabhu SS; Gasco J; Tummala S; Weinberg JS; Rao G
    J Neurosurg; 2011 Mar; 114(3):719-26. PubMed ID: 20964594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Awake craniotomy for brain tumor resection: the rule rather than the exception?
    Brown T; Shah AH; Bregy A; Shah NH; Thambuswamy M; Barbarite E; Fuhrman T; Komotar RJ
    J Neurosurg Anesthesiol; 2013 Jul; 25(3):240-7. PubMed ID: 23603885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Awake Craniotomy in Arteriovenous Malformation Surgery: The Usefulness of Cortical and Subcortical Mapping of Language Function in Selected Patients.
    Gamble AJ; Schaffer SG; Nardi DJ; Chalif DJ; Katz J; Dehdashti AR
    World Neurosurg; 2015 Nov; 84(5):1394-401. PubMed ID: 26142811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safe Resection of Gliomas of the Dominant Angular Gyrus Availing of Preoperative FMRI and Intraoperative DTI: Preliminary Series and Surgical Technique.
    D'Andrea G; Familiari P; Di Lauro A; Angelini A; Sessa G
    World Neurosurg; 2016 Mar; 87():627-39. PubMed ID: 26548825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of Gamma Knife surgery for brain metastases in eloquent locations.
    Dea N; Borduas M; Kenny B; Fortin D; Mathieu D
    J Neurosurg; 2010 Dec; 113 Suppl():79-83. PubMed ID: 21218534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring.
    Feigl GC; Ritz R; Moraes M; Klein J; Ramina K; Gharabaghi A; Krischek B; Danz S; Bornemann A; Liebsch M; Tatagiba MS
    J Neurosurg; 2010 Aug; 113(2):352-7. PubMed ID: 19911888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Awake Craniotomy for Resection of Brain Metastases: A Systematic Review.
    Chua TH; See AAQ; Ang BT; King NKK
    World Neurosurg; 2018 Dec; 120():e1128-e1135. PubMed ID: 30205215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li YM; Suki D; Hess K; Sawaya R
    J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraoperative neuromonitoring for function-guided resection differs for supratentorial motor eloquent gliomas and metastases.
    Obermueller T; Schaeffner M; Shiban E; Droese D; Negwer C; Meyer B; Ringel F; Krieg SM
    BMC Neurol; 2015 Oct; 15():211. PubMed ID: 26487091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraoperative monopolar mapping during 5-ALA-guided resections of glioblastomas adjacent to motor eloquent areas: evaluation of resection rates and neurological outcome.
    Schucht P; Seidel K; Beck J; Murek M; Jilch A; Wiest R; Fung C; Raabe A
    Neurosurg Focus; 2014 Dec; 37(6):E16. PubMed ID: 25434385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and clinical evolution of postoperative deficits after volumetric stereotactic resection of glial neoplasms involving the supplementary motor area.
    Russell SM; Kelly PJ
    Neurosurgery; 2003 Mar; 52(3):506-16; discussiom 515-6. PubMed ID: 12590674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies to maximize resection of complex, or high surgical risk, low-grade gliomas.
    Wilden JA; Voorhies J; Mosier KM; O'Neill DP; Cohen-Gadol AA
    Neurosurg Focus; 2013 Feb; 34(2):E5. PubMed ID: 23373450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative ischemic changes after glioma resection identified by diffusion-weighted magnetic resonance imaging and their association with intraoperative motor evoked potentials.
    Gempt J; Krieg SM; Hüttinger S; Buchmann N; Ryang YM; Shiban E; Meyer B; Zimmer C; Förschler A; Ringel F
    J Neurosurg; 2013 Oct; 119(4):829-36. PubMed ID: 23829818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Awake craniotomy for brain tumours].
    Milos P; Metcalf K; Vigren P; Lindehammar H; Nilsson M; Boström S
    Lakartidningen; 2016 Oct; 113():. PubMed ID: 27727417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Awake craniotomy and electrophysiological mapping for eloquent area tumours.
    Chacko AG; Thomas SG; Babu KS; Daniel RT; Chacko G; Prabhu K; Cherian V; Korula G
    Clin Neurol Neurosurg; 2013 Mar; 115(3):329-34. PubMed ID: 23177182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Operative treatment of subcortical metastatic tumours in the central region.
    Walter J; Kuhn SA; Waschke A; Kalff R; Ewald C
    J Neurooncol; 2011 Jul; 103(3):567-73. PubMed ID: 20878448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.